1. Human papillomavirus types 16 E1 mRNA is transcribed from P14 early promoter in cervical neoplasms.
- Author
-
Fedorova M, Vinokurova S, Pavlova L, Komel'kov A, Korolenkova L, Kisseljov F, and Kisseljova N
- Subjects
- Carcinoma, Squamous Cell virology, Female, Humans, RNA, Messenger biosynthesis, RNA, Viral biosynthesis, Real-Time Polymerase Chain Reaction, Uterine Cervical Dysplasia virology, Human papillomavirus 16 genetics, Oncogene Proteins, Viral genetics, Promoter Regions, Genetic, RNA, Messenger analysis, RNA, Viral analysis, Transcription, Genetic, Uterine Cervical Neoplasms virology
- Abstract
High-risk human papillomavirus (HR-HPV) persistent infection is responsible for the development of the majority of cervical cancers. The therapy against HPV-associated cancer requires knowledge of the viral gene expression mechanisms. In this study, the polyadenylated polycistronic transcripts containing full-size E1ORF and produced from the early P14 promoter were detected for the first time in cervical tumors with episomal forms of the HPV16 genome. P14-initiated mRNAs were revealed also in precancerous lesions. The amount of P14-initiated transcripts was significantly less compared to transcripts initiated from the major P97 HPV16 promoter in cervical intraepithelial neoplasms and squamous cell carcinomas. The ratios of P97/P14-transcripts determined by qRT-PCR were unique for each clinical sample and varied in quite wide ranges independent of disease progression stages or tumor grade. These data suggest that the levels of P14- and P97-transcripts are regulated independently from each other in cervical neoplasms., (Copyright © 2015 Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF